RCKT Operating Income Growth
Rocket Pharmaceuticals Inc · Operating Income Growth
RCKT Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported28.40%period ending
RCKT TTM Operating Income YoY % (-81.06% → 28.40%)
Year-over-year change
High-resolution chart · PNG
RCKT operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 28.3992% | |
| 20.1126% | |
| 15.1747% | |
| 8.5146% | |
| 0.7932% | |
| -2.0307% | |
| -5.2168% | |
| -3.1372% | |
| -4.361% | |
| -8.5526% | |
| -15.7415% | |
| -33.0003% | |
| -35.5266% | |
| -43.0169% | |
| -34.1377% | |
| -9.5749% | |
| -19.2989% | |
| -14.1795% | |
| -24.5302% | |
| -92.318% | |
| -84.8647% | |
| -83.7125% | |
| -76.3654% | |
| -14.0499% | |
| -9.1877% | |
| -7.4391% | |
| -7.0213% | |
| -70.1364% | |
| -97.0915% | |
| -142.7989% | |
| -166.1293% | |
| -40.3692% | |
| -3.6304% | |
| 25.2518% | |
| 36.1565% | |
| 8.1705% | |
| -19.0351% | |
| -51.7537% | |
| -105.3295% | |
| -172.8242% | |
| -209.4501% | |
| -203.9929% | |
| -164.7456% | |
| -81.0592% |